BackgroundLower urinary tract symptomatology secondary to benign prostatic hyperplasia is one of the most common pathologies in men, and transurethral resection of the prostate is the technique of choice for its surgical management. However, in the last few years new technology and techniques have been developed, such as Holmium laser enucleation of the prostate (HoLEP), that have had good functional results and less comorbidity. Transurethral enucleation of the prostate with bipolar energy (TUEB) is a novel technique that has also shown adequate results. AimsTo describe the experience of the first 20 cases of patients that underwent enucleation of the prostate with bipolar energy. MethodsTwenty patients were selected that presented with severe lower urinary tract symptoms, despite medical treatment with alpha blockers, and that had prostate volumes ranging from 50-80 cc and adenomas from 30-50 cc. Bipolar electrosurgical equipment with 120 W coagulation energy and 220 W cutting energy was placed over a 26 Fr continuous flow resectoscope (Olympus®); irrigation was carried out with saline solution and a morcellation unit connected to a suction pump was used for extracting the enucleated tissue. ResultsMean surgery duration was 102 min and mean enucleation time was 41.2 min. The quantity of morcellated tissue was 58.5 g, none of the patients presented with prostate capsule perforation, and the mean postoperative hospital stay was 27.8 h. In regard to follow-up, the mean IPSS score was 4.5 points, residual volumes measured 34.3 ml, and Qmax was 18.5 ml/sec. DiscussionAmong the new techniques currently available for the surgical treatment of prostate hyperplasia, transurethral resection is the treatment of choice. However, laser enucleation of the prostate is a novel procedure that has shown good long-term clinical results. Enucleation of the prostate with bipolar energy has emerged as an alternative to HoLEP, offering the patient a lower cost and good results. ConclusionsThe technique of bipolar enucleation of the prostate is an important alternative to transurethral resection of the prostate and retropubic prostatectomy. It has the advantage that it can be performed regardless of prostate volume and it achieves total resection of the adenoma, with fewer intraoperative and postoperative complications.